Form 4: Health In Tech CEO Granted 1 Million Restricted Shares

Health In Tech CEO Tim Johnson received 1 million restricted Class A Common Stock shares tied to future transactions and continued service, increasing his beneficial ownership.

Summary

• Tim Donald Johnson, CEO, Director, and 10% Owner of Health In Tech, Inc. [HIT], acquired 1,000,000 restricted shares of Class A Common Stock.
• The transaction occurred on January 6, 2026, with a price of $0 per share, granted under the Health in Tech Equity Incentive Plan.
• The vesting of these shares is contingent on the closing of two proposed issuer transactions.
• Half of the shares vest in equal monthly installments over 12 months starting at the closing of the first transaction, and the other half vest over 12 months starting at the closing of the second transaction.
• Vesting is subject to continued service by Mr. Johnson.
• If either proposed transaction does not close within 24 months after January 6, 2026, the unvested shares related to that transaction will be automatically forfeited without consideration.
• Following this transaction, Mr. Johnson beneficially owns 23,549,741 shares of Class A Common Stock, comprising 1,126,130 restricted shares and 22,423,611 unrestricted shares.
• This total excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase Class A Common Stock.

Sentiment

Score: 7

Explanation: The grant of restricted shares to the CEO, tied to future strategic transactions and continued service, generally indicates a positive alignment of interests and potential for growth. However, the forfeiture condition introduces a degree of uncertainty regarding the successful completion of these transactions.

Positives

• The grant of restricted shares to the CEO aligns management's interests with long-term company performance and the successful completion of strategic transactions.
• The equity incentive plan encourages executive retention through continued service requirements.
• The grant is tied to the successful closing of two proposed issuer transactions, suggesting potential strategic growth or M&A activity.

Negatives

• The shares are restricted and subject to forfeiture if the proposed transactions do not close within 24 months, introducing uncertainty.
• The $0 acquisition price for 1,000,000 shares could be seen as dilutive if not properly justified by future performance.

Risks

• Transaction Risk: The vesting of 1,000,000 restricted shares is contingent on the closing of two proposed issuer transactions. If these transactions do not close within 24 months after January 6, 2026, the related unvested shares will be forfeited, indicating a risk associated with the successful completion of these strategic initiatives.
• Forfeiture Risk: Unvested shares are subject to automatic forfeiture without consideration if the underlying transactions do not materialize within the specified timeframe.
• Service Risk: Vesting is subject to continued service, meaning Mr. Johnson must remain employed for the shares to fully vest.

Future Outlook

The grant of restricted shares is tied to the successful closing of two proposed issuer transactions, indicating potential strategic growth or M&A activities in the future. The vesting schedule suggests these transactions are expected to close within 24 months of January 6, 2026.

Management Comments

• "Represents restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan in connection with two proposed issuer transactions."
• "Half of the shares vest in equal monthly installments over 12 months starting at the closing of the first Transaction."
• "The other half vest in equal monthly installments over 12 months starting at the closing of the second Transaction."
• "Vesting is subject to continued service."
• "If either Transaction does not close within 24 months after January 6, 2026, unvested shares relating to that Transaction will be automatically forfeited without consideration."

Industry Context

na

Corporate Governance

Related Party Transactions

• Grant of 1,000,000 restricted shares of Class A Common Stock to Tim Donald Johnson, the Chief Executive Officer, Director, and 10% Owner of Health In Tech, Inc., under the company's Equity Incentive Plan. This is a direct transaction between the company and a key insider.

Stakeholder Impact

• Shareholders: Potential for increased long-term value if the proposed transactions are successful and the CEO's incentives are aligned. However, the grant could be dilutive if not justified by future performance.
• Employees: The grant to the CEO under an equity incentive plan may signal a commitment to performance-based compensation, potentially influencing broader employee incentive structures.
• Management (Tim Johnson): Significant incentive to ensure the successful completion of the two proposed issuer transactions and to maintain continued service to the company.

Next Steps

• Closing of the first proposed issuer transaction, triggering the vesting of 500,000 restricted shares.
• Closing of the second proposed issuer transaction, triggering the vesting of the remaining 500,000 restricted shares.
• Continued service by Tim Johnson to ensure vesting of shares.
• Monitoring the 24-month deadline from January 6, 2026, for the closing of the proposed transactions to avoid forfeiture.

Key Dates

Recommendation

While the grant of restricted shares to the CEO aligns management incentives with future strategic transactions, the details of these "proposed issuer transactions" are not disclosed. The success of these transactions is crucial for the vesting of the shares and potentially for the company's growth. Without more information on these transactions, it's difficult to assess the full impact. The current information suggests a commitment to future growth but also introduces a contingent risk. Therefore, a 'hold' recommendation is appropriate until further details on the proposed transactions become available.

Keywords

Health In Tech, HIT, Tim Johnson, Form 4, Insider Trading, Restricted Stock, Equity Incentive Plan, CEO Compensation, Stock Grant, Beneficial Ownership, Corporate Governance, Executive Compensation, SEC Filing